Mutual of America Capital Management LLC Decreases Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Mutual of America Capital Management LLC decreased its position in ICU Medical, Inc. (NASDAQ:ICUI) by 73.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,549 shares of the medical instruments supplier’s stock after selling 9,632 shares during the period. Mutual of America Capital Management LLC’s holdings in ICU Medical were worth $354,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. M&T Bank Corp increased its stake in shares of ICU Medical by 5.4% during the 3rd quarter. M&T Bank Corp now owns 4,661 shares of the medical instruments supplier’s stock worth $555,000 after purchasing an additional 239 shares during the last quarter. Knights of Columbus Asset Advisors LLC increased its stake in shares of ICU Medical by 16.7% during the 3rd quarter. Knights of Columbus Asset Advisors LLC now owns 1,848 shares of the medical instruments supplier’s stock worth $220,000 after purchasing an additional 264 shares during the last quarter. Gamco Investors INC. ET AL increased its stake in shares of ICU Medical by 1.1% during the 3rd quarter. Gamco Investors INC. ET AL now owns 24,950 shares of the medical instruments supplier’s stock worth $2,969,000 after purchasing an additional 278 shares during the last quarter. Private Trust Co. NA increased its stake in shares of ICU Medical by 1,428.6% during the 3rd quarter. Private Trust Co. NA now owns 321 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 300 shares during the last quarter. Finally, Xponance Inc. increased its stake in shares of ICU Medical by 17.8% during the 3rd quarter. Xponance Inc. now owns 2,902 shares of the medical instruments supplier’s stock worth $345,000 after purchasing an additional 439 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Up 1.4 %

ICUI opened at $97.76 on Wednesday. The company has a 50 day moving average of $102.12 and a 200 day moving average of $98.06. The company has a market cap of $2.38 billion, a PE ratio of -79.48 and a beta of 0.69. ICU Medical, Inc. has a 12 month low of $78.28 and a 12 month high of $212.43. The company has a current ratio of 2.53, a quick ratio of 1.06 and a debt-to-equity ratio of 0.74.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 EPS for the quarter, topping the consensus estimate of $0.85 by $0.39. The company had revenue of $587.86 million during the quarter, compared to the consensus estimate of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. On average, sell-side analysts expect that ICU Medical, Inc. will post 3.52 EPS for the current year.

Insider Buying and Selling

In related news, VP Daniel Woolson sold 791 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares of the company’s stock, valued at approximately $1,373,814.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other ICU Medical news, Director George A. Lopez sold 7,978 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $101.87, for a total value of $812,718.86. Following the completion of the transaction, the director now directly owns 877,343 shares of the company’s stock, valued at approximately $89,374,931.41. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Daniel Woolson sold 791 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares of the company’s stock, valued at $1,373,814.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 24,262 shares of company stock valued at $2,545,532. Company insiders own 6.70% of the company’s stock.

Wall Street Analyst Weigh In

Separately, KeyCorp raised their price target on shares of ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 28th. One research analyst has rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, ICU Medical currently has an average rating of “Moderate Buy” and an average target price of $123.00.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.